By L.B. Bohle
To get in touch with L.B. Bohle, simply fill out the form below.
Subscribe to Supplier
L.B. BOHLE to highlight QBCon® continuous manufacturing advances at PBP 2022 Rotterdam
Ennigerloh, Germany: – World-respected builder of advanced systems for pharma production, L.B. Bohle, will be a high profile presence at the 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP2022) in The Netherlands port city of Rotterdam.
L.B. Bohle will be an exhibitor at the event, showcasing its world-renowned range of specialist pharmaceutical production solutions at Booth 54 in the ResearchPharm® exhibition zone at Rotterdam’s RACC convention center, with emphasis on its recent advances in continuous manufacturing technology.
Continuous manufacturing advances
The facility’s Innovation Center will features a wide range of equipment and services, including product formulation and optimization, training, tablet production trials, as well as a module plant for continuous manufacturing of solids. L.B. Bohle will also contribute to the PBP scientific program, with Dr. Robin Meier, Manager of Scientific Operations, presenting observations on “QbCon – A breakthrough in continuous granulation and drying”.
Throughout the event, L.B. Bohle will highlight the contribution its QbCon® series machines and processes are making to advancing continuous manufacturing opportunities in oral solid dose (OSD) production and elsewhere in the pharma industry.
About L.B. Bohle
Founded in 1981, L.B. Bohle Maschinen und Verfahren GmbH (L.B. Bohle) has established a worldwide reputation as a producer and supplier of advanced systems for pharmaceutical manufacturing, based on a track record of technological innovation and continuous improvement.
Based at Ennigerloh in Northwest Germany, L.B. Bohle operates worldwide, offering advanced solutions for every aspect of oral solid dose (OSD) and nutraceutical tablet production, including weighing & dosing, grinding & sieving, blending, tablet coating, sorting, handling systems, cleaning and containment, process monitoring and continuous manufacturing.
The company’s guiding vision is one of technological innovation in the production of pharmaceutical solids. This supports a core mission to deliver maximum product efficiency increases for its customers, through continuous development and product innovations that not only increase quality and efficiency, but also strengthen competitive edge and sustainability.
The company operates development and manufacturing facilities at its home base at Ennigerloh and at Sassenberg, both in North Rhine-Westphalia. Additionally it has sales and service subsidiaries in the USA (Warminster, PA) in India (Ahmedabad) , in Singapore and in Switzerland (Reiden). It is also represented by more than 40 qualified sales partners worldwide, having become a globally recognized brand.
Further information at: http://www.lbbohle.com/
About PBP 2022
The Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP) World Meeting has become a well-established pharma industry event, attracting scientists from all over the world. The event is biennial, with previous meetings held in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow, and Granada (2018), with a 2021 event held online because of the Covid-19 pandemic.
The 13th World Meeting, PBP 2022, is held over four days, opening March 28 at the RACC Rotterdam Ahoy Convention Center in The Netherlands.
The event is expected to attract around 1,000 delegates with hundreds of 1000 abstracts posted.
The conference and the accompanying ResearchPharm® exhibition provide a cross-disciplinary platform for pharmaceutical scientists working in all fields of drug product development in industry, academia and regulation.
PBP 2022 will have parallel sessions on industry-related topics presented by distinguished invited speakers along with two further parallel tracks for oral presentations on Pharmaceutics, Biopharmaceutics and Pharma Technology.